CRL
Charles River Laboratories International, Inc. · Healthcare
Director Richard F Wallman sold $2.1M of Charles River Laboratories International, Inc.
Sold$2,108,413
$292.84Price
7,200Shares
−29%Stake
What CRL did after the filing
- The stock from Thu, Feb 24 open, $277.12
- +9.0%
- S&P 500, same days
- +9.5%
Measured over 30 trading days, to the Apr 7 close.
Traded Fri, Feb 18. Filed Wed, Feb 23, 4:07 PM ET, after the close. Returns use the Feb 24 open and the Apr 7 close. Not investment advice.